Cited by 37Acute Myocardial Infarction ResearchInflammatory Biomarkers in Disease PrognosisAntiplatelet Therapy and Cardiovascular Diseases

Relation Between Hemoglobin Level and Recurrent Myocardial Ischemia in Acute Coronary Syndromes Detected by Continuous Electrocardiographic Monitoring

Rousseau, Melissa, Yan, Raymond T., Tan, Mary, Lefkowitz, Charles J., Casanova, Amparo, Fitchett, David, Jolly, Sanjit S., Langer, Anatoly +2 more·2010·The American Journal of Cardiology

Abstract

Anemia has been associated with adverse outcomes in patients with acute coronary syndromes (ACS). However, the underlying pathophysiologic mechanisms have not been well elucidated. We sought to determine the independent relation between the hemoglobin level and recurrent ischemia in patients with non-ST-segment elevation ACS using continuous electrocardiographic monitoring. In the Integrilin and Enoxaparin Randomized Assessment of Acute Coronary Syndrome Treatment (INTERACT) trial, 746 patients presenting with non-ST-segment elevation ACS underwent continuous ST-segment monitoring for 48 hours. The data were analyzed independently at a core laboratory. We stratified the study population according to their hemoglobin level on presentation. The primary outcome of the study was recurrent ischemia, defined as ST-segment shifts on continuous electrocardiographic monitoring. Of the 705 patients with analyzable data, 64 had a baseline hemoglobin level <120 g/L, 259 had a level of 120 to 139 g/L, 315 had a level of 140 to 159 g/L, and 67 had a level >160 g/L. The corresponding rates of recurrent ischemia were 39.1%, 22.0%, 15.6%, and 11.9% (p for trend <0.001). A lower hemoglobin level was associated with advanced age, co-morbidities, and a higher GRACE risk score. In multivariable analysis adjusting for these confounders, lower hemoglobin levels retained a significant independent association with recurrent ischemia (p for trend = 0.004). In conclusion, a lower hemoglobin level at presentation was independently associated with recurrent ischemia detected by continuous electrocardiographic monitoring in the setting of non-ST-segment elevation ACS. This suggests that anemia might predispose patients to recurrent ischemia, which could be an important underlying mediator of worse outcomes in patients with lower hemoglobin levels.

Integrity signals

Registry

Crossref · 10.1016/j.amjcard.2010.07.009

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Therapeutic interventions aimed to increase the circulating number of RBCs (transfusion of blood or administration of erythropoiesis-stimulating agents) were not always effective in the tested cohorts.

    “However, therapeutic interventions aimed to increase the circulating number of RBCs (e.g., by transfusion of blood or by administration of erythropoiesis-stimulating agents [ESAs] to stimulate the production of RBCs by the bone marrow), were not always effective in the tested cohorts (48, 91, 156).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Rousseau, M., Yan, R. T., Tan, M., Lefkowitz, C. J., Casanova, A., Fitchett, D., Jolly, S. S., Langer, A., Goodman, S. G., & Yan, A. T.
Affiliations
  • St. Michael's Hospital (CA)
  • Canadian Heart Research Centre (CA)
  • University of Toronto (CA)
  • Population Health Research Institute (CA)
Corresponding author
Yan, Andrew T.
Venue
The American Journal of Cardiology
Publisher
Elsevier BV
Published
2010-11
Volume
106
Issue
10
Pages
1417-1422
ISSN
0002-9149 (ISSN-L)
OpenAlex
W1972706572
Cited by
37
References
30
Citations by year
2026: 1 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 2 · 2019: 3 · 2018: 3 · 2017: 3 · 2016: 6 · 2015: 3 · 2014: 6 · 2012: 3
FWCI
1.10
Type
journal article
Language
en
Open access
closed
Locations
  • The American Journal of Cardiology (publishedVersion)
  • PubMed (publishedVersion)
Funders
Heart and Stroke Foundation of Canada
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
  • Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
Keywords
hemoglobin levels, anemia, recurrent myocardial ischemia, non-ST-elevation acute coronary syndrome, INTERACT trial, GRACE risk score
MeSH terms
Aged, Female, Hemoglobins, Humans, Male, Middle Aged, Prospective Studies, Recurrence, Electrocardiography, Ambulatory, Randomized Controlled Trials as Topic, Myocardial Ischemia, Acute Coronary Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review